Delcath Systems Inc
NASDAQ:DCTH
Delcath Systems Inc
NASDAQ:DCTH
Price:
5.2 USD
-0.19%
Market Closed
Updated:
May 1, 2024
Section:
Relative Value
The Relative Value of one
DCTH
stock under the Base Case scenario is
9.6
USD.
Compared to the current market price of 5.2 USD,
Delcath Systems Inc
is
Undervalued by 46%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DCTH
Relative Value
Base Case
9.6
USD
Undervaluation 46%
Valuation Multiples
Multiples Across Competitors
DCTH Competitors Multiples
Delcath Systems Inc Competitors
Delcath Systems Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Delcath Systems Inc
NASDAQ:DCTH
|
132.3m USD | 64.1 | -2.8 | -2.6 | -2.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.8B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
131.5B USD | 18 | 66.1 | 54.2 | 68 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.9B USD | 6.2 | 40.4 | 25.2 | 31.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.7B USD | 3.3 | 25.4 | 13.6 | 19.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.3B USD | 7.4 | 67.1 | 31.2 | 46.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 3.5 | 55.6 | 18.6 | 39.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.1B EUR | 2.7 | 38.3 | 18.4 | 31 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.9B USD | 8.5 | 36.3 | 26.2 | 28.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49.1B USD | 13.6 | 90.7 | 61.1 | 79.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
